INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 15 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 112 | +3.7% | 0.00% | – |
| Q4 2021 | $0 | – | 108 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 108 | -17.6% | 0.00% | – |
| Q2 2021 | $0 | – | 131 | +322.6% | 0.00% | – |
| Q1 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 31 | -3.1% | 0.00% | – |
| Q3 2020 | $0 | – | 32 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 32 | -95.9% | 0.00% | – |
| Q1 2020 | $1,000 | – | 786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|